Sources and updates, October 30
Sources and updates for the week of October 30 include booster shot demographics, mortality data by occupation, Paxlovid prescriptions, and more.
Read MoreCategory: Vaccines
Sources and updates, October 23
Sources and updates for the week of October 23 include flu vaccination disparities, genomic surveillance from travelers, hospital finances, and more.
Read MoreNational numbers, October 16
While official case numbers remain low compared to past fall seasons—both national cases and hospital admissions dropped again this week—signals of a coming fall surge are accumulating from wastewater and local data. According to Biobot’s dashboard, the coronavirus continues to spread in the Northeast at higher levels than the rest of the country with a new uptick this week.
Read MoreCOVID source shout-out: Bloomberg’s vaccine tracker
Last week, the team behind Bloomberg’s COVID-19 vaccine tracker announced that the dashboard will stop updating on October 5. Thank you to this team for your work tracking the vaccine rollout!
Read MoreThe U.S. needs to step up its booster shot campaign
New, Omicron-specific booster shots are publicly available for all American adults who’ve been previously vaccinated. But awareness of the shots and uptake so far are both incredibly low.
Read MoreNational numbers, September 25
Nationally, official COVID-19 case counts continue to decline: reported cases are down about 11% last week compared to the prior week, while new COVID-19 patients in hospitals are down 10%. But signals from wastewater and variants suggest a fall surge may be starting soon.
Read MoreCOVID-19 risk factors that should lead to Omicron booster priority
Unlike previous vaccination campaigns, the new Omicron boosters are available to all adults across the country who have been previously inoculated. But all previously-vaccinated Americans are not facing similar levels of COVID-19 risk.
Read MoreData considerations for the new Omicron-specific booster shots
This week, the FDA and CDC authorized new booster shots from both Pfizer and Moderna that are tweaked to specifically target Omicron BA.4 and BA.5. Here are some data considerations for the new boosters.
Read MoreSources and updates, July 31
Sources and updates for the week of July 31 include slow vaccine uptake for young kids, next-generation vaccines, COVID-19’s origins, and more.
Read MoreWe need more data for fall booster decisions
This week, the FDA’s vaccine advisory committee met to discuss fall booster shots, in anticipation of another COVID-19 surge next winter. The discussion demonstrated the U.S.’s continued failure to provide the data that are really needed to make these decisions.
Read More